The Role of Clinical and Instrumented Outcome Measures in Balance Control of Individuals with Multiple Sclerosis

被引:18
|
作者
Kanekar, Neeta [1 ]
Aruin, Alexander S. [1 ]
机构
[1] Univ Illinois, Dept Phys Therapy, 1919 West Taylor St, Chicago, IL 60612 USA
关键词
D O I
10.1155/2013/190162
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose. The aim of the study was to investigate differences in balance control between individuals with multiple sclerosis (MS) and healthy control subjects using clinical scales and instrumented measures of balance and determine relationships between balance measures, fatigue, and disability levels in individuals with MS with and without a history of falls. Method. Twelve individuals with MS and twelve healthy controls were evaluated using the Berg Balance and Activities-specific Balance Confidence Scales, Modified Clinical Test of Sensory Interaction on Balance, and Limits of Stability Tests as well as Fatigue Severity Scale and Barthel Index. Results. Mildly affected individuals with MS had significant balance performance deficits and poor balance confidence levels (P < 0.05). MS group had higher sway velocities and diminished stability limits (P < 0.05), significant sensory impairments, high fatigue and disability levels (P < 0.05). Sway velocity was a significant predictor of balance performance and the ability to move towards stability limits for the MS group. For the MS-fallers group, those with lower disability levels had faster movement velocities and better balance performance. Conclusion. Implementation of both clinical and instrumented tests of balance is important for the planning and evaluation of treatment outcomes in balance rehabilitation of people with MS.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Clinical outcome measures in multiple sclerosis
    Amato, Maria Pia
    Portaccio, Emilio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 259 (1-2) : 118 - 122
  • [2] Longitudinal measures of instrumented gait and balance in multiple sclerosis over 18 months
    Spain, R.
    Mancini, M.
    St George, R.
    Bourdette, D.
    Horak, F.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 330 - 331
  • [3] Clinical outcome measures for research in multiple sclerosis
    Balcer, LJ
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2001, 21 (04) : 296 - 301
  • [4] Outcome Measures in Clinical Trials for Multiple Sclerosis
    van Munster, Caspar E. P.
    Uitdehaag, Bernard M. J.
    CNS DRUGS, 2017, 31 (03) : 217 - 236
  • [5] Outcome Measures in Clinical Trials for Multiple Sclerosis
    Caspar E. P. van Munster
    Bernard M. J. Uitdehaag
    CNS Drugs, 2017, 31 : 217 - 236
  • [6] Outcome measures in multiple sclerosis clinical trials
    Andersson, PB
    Goodkin, DE
    BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (03): : 409 - 428
  • [7] Clinical outcome measures in multiple sclerosis: A review
    Inojosa, Hernan
    Schriefer, Dirk
    Ziemssen, Tjalf
    AUTOIMMUNITY REVIEWS, 2020, 19 (05)
  • [8] Outcome measures for physical fatigue in individuals with multiple sclerosis: a systematic review
    Sellitto, Giovanni
    Morelli, Alessia
    Bassano, Susanna
    Conte, Antonella
    Baione, Viola
    Galeoto, Giovanni
    Berardi, Anna
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (04) : 625 - 646
  • [9] Outcome measures for multiple sclerosis
    Osborne, Lisa
    Noble, J.
    Maramba, Inocencio
    Jones, Kerina
    Middleton, Rodden
    Lyons, Ronan
    Ford, David
    Reed, Phil
    PHYSICAL THERAPY REVIEWS, 2014, 19 (01) : 24 - 38
  • [10] Outcome Measures in Multiple Sclerosis
    Bermel, Robert
    Waldman, Amy
    Mowry, Ellen M.
    MULTIPLE SCLEROSIS INTERNATIONAL, 2014, 2014